The Centre of Excellence in Pharmacovigilance at JSS College of Pharmacy, Mysuru, stands as a beacon of innovation and expertise in the realm of patient safety and medication risk management. Established with a vision to safeguard public health, this Centre has evolved into a pivotal hub for pharmacovigilance activities in India, particularly in the southern region.
Nestled within the Department of Clinical Pharmacy at JSS Hospital, the Centre leverages its strategic position to bridge academic research with real-world clinical practice. This unique positioning allows for the seamless integration of theoretical knowledge with practical applications, fostering a comprehensive approach to pharmacovigilance.
As a recognized leader in the field, the Centre has cultivated strong partnerships with international organizations such as the World Health Organization and Uppsala Monitoring Centre, as well as national bodies like the Pharmacovigilance Programme of India. These collaborations have positioned the Centre at the forefront of global pharmacovigilance initiatives, enabling it to contribute significantly to both national and international patient safety efforts.
The Centre's multifaceted approach encompasses rigorous research, innovative education programs, and proactive risk management strategies. By focusing on areas such as adverse drug reaction monitoring, vaccine safety surveillance, and medication error reporting, the Centre addresses critical aspects of patient safety across the healthcare spectrum.
With state-of-the-art facilities, a dedicated team of experts, and a commitment to excellence, the Centre of Excellence in Pharmacovigilance continues to shape the future of patient safety, not only in India but also on the global stage. Its ongoing efforts in capacity building, research, and collaboration underscore its vital role in advancing the field of pharmacovigilance and ultimately improving patient outcomes worldwide.
Facilities Available and Technical support to other AMCs - Karnataka, Pondicherry, and Lakshadweep.
The Centre of Excellence in Pharmacovigilance conducts research in the area of Outcomes research, focusing on improving the real-world safety and effectiveness of medicines. Outcomes research evaluates how medications perform in routine clinical practice, assessing their impact on patient health, quality of life, and healthcare utilization. These insights support evidence-based treatment decisions and policy development. Patient safety surveillance is a key pharmacovigilance activity that involves continuous monitoring of adverse drug reactions and safety signals following the marketing of medicines. Through systematic data collection and analysis, potential risks are identified early, enabling timely risk-minimization actions and regulatory updates. Medication-related problems, including adverse drug reactions, medication errors, drug interactions, and inappropriate use, remain major challenges in healthcare. Pharmacovigilance helps detect, assess, and prevent these issues, promoting safer medication use and better patient outcomes. Together, outcomes research and safety surveillance strengthen healthcare systems and support the ongoing protection of patient safety.